You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 145 No. 8, August 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Photosensitivity Disorders
 •Dermatologic Disorders, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

VIGNETTES
Adult-Onset Erythropoietic Porphyria in the Setting of MDS

Christina Cernik, MD; Nairmeen Haller, PhD; Eliot N. Mostow, MD, MPH

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Report of a Case

In September 2004, an 81-year-old man with myelodysplastic syndrome (MDS) presented with a 6-week history of painful, pruritic lesions on his ears, scalp, and the dorsal surface of his hands. His urine was red-brown. The use of alcohol and/or new medications and exposure to chemicals and/or radiation were denied. Biopsy specimens revealed subepidermal blistering with few polymorphonuclear cells, abundant solar elastotic material, and homogeneous eosinophilic material surrounding upper dermis small vessels, all fairly nonspecific findings. Urine porphyrin analysis revealed massively elevated porphyrin levels in a pattern consistent with congenital erythropoietic porphyria (CEP). Bacitracin ointment and diphenhydramine treatments were started, but the patient was lost to follow-up.

In August 2007, the patient returned. He was receiving weekly transfusions of packed red blood cells and platelets as treatment for his MDS, and he noted that his cutaneous lesions consistently flared after . . . [Full Text of this Article]


Comment

AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.